Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24032890
Abstract: Rilpivirine is an antiretroviral drug used to treat AIDS worldwide. The drug is a non-nucleoside reverse transcriptase inhibitor that halts the cDNA elongation process and, thus, the capacity of the HIV-1 virus to replicate. With… read more here.
Keywords: rilpivirine; oncology; evolution antiretroviral; antiretroviral drug ... See more keywords